Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals.
Francesco Paolo RussoAlberto ZanettoElena CampelloCristiana BulatoSarah ShalabyLuca SpieziaSabrina GavassoEnrica FranceschetClaudia RaduMarco SenzoloPatrizia BurraJ P LuyendykPaolo SimioniPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
DAAs therapy in HCV-related cirrhotic patients is associated with significant changes in thrombin generation suggesting a reversal of hypercoagulability particularly in Child's A patients.